Found 36 results
Author Title [ Type(Desc)] Year
Filters: Author is Tejani, A  [Clear All Filters]
Journal Article
M. Benfield, McDonald, R., Sullivan, E. K., Stablein, D., and Tejani, A., The 1997 Annual report of the North American Pediatric Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 3, no. 2, pp. 152-167, 1999.
R. McDonald, Ho, P. L., Stablein, D. M., and Tejani, A., Acute rejection rate, time to first rejection and rejection reversals comparing the 1987-1989 pediatric renal transplant recipient cohort to the 1997-1999 cohort. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), 2000.
D. Stablein, Emmett, L., and Tejani, A., After six thousand transplants where are we? The state of pediatric renal transplantation in North America, 2000.
A. Tejani, Stablein, D., Alexander, S., Fine, R., and Harmon, W., Analysis of Rejection Outcomes and Implications. A Report of the North American Pediatric Renal Transplant Cooperative Study, Transplantation, vol. 59, no. 4, pp. 500-504, 1995.
J. M. Sorof, Sullivan, E. K., Tejani, A., and Portman, R. J., Antihypertensive medication and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), J Am Soc Nephrol, vol. 10, pp. 1324-30, 1999.
A. Tejani, Stablein, D. M., and Ho, P. L., Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials, 2002.
M. Benfield, Tejani, A., and Ho, P. L., Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT), 2002.
A. Tejani and Sullivan, E. K., Do six-antigen matched cadaver donor (CAD) kidneys provide better graft survival to children compared to one-haploidentical living-related (LRD) transplants? A report of the North American Pediatric Cooperative Study (NAPRTCS), 1999.
I. Elshihabi, Stablein, D. M., and Tejani, A., Emerging immunosuppressive profile of pediatric renal transplant recipients and its impact on graft survival, 2000.
I. Elshihabi, Stablein, D. M., and Tejani, A., Emerging immunosuppressive profile of pediatric renal transplant recipients and its impact on graft survival, 2000.
A. Tejani and Sullivan, E. K., Factors that Impact on the Outcome of Second Renal Transplants in Children, Transplantation, vol. 62, no. 5, pp. 606-611, 1996.
D. M. Stablein and Tejani, A., Five-Year Patient and Graft Survival in North American Children: A Report of The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Kidney Int Suppl, vol. 43, pp. S16-S21, 1993.
S. Schurman, Stablein, D. M., Garin, E. H., and Tejani, A., For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Impact of puberty on renal function in children with chronic renal insufficiency (CRI), 2000.
M. A. Baum, Stablein, D., Panzarino, V. M., Tejani, A., and Harmon, W., Graft loss due to recurrence eliminates the graft survival advantage of living donor (LD) over Cadaveric (CD) renal transplants (Tx) in children with focal segmental glomerulosclerosis (FSGS): A report of the North American Pediatric Transplant Cooperati, 1999.
A. Tejani and Sullivan, E. K., Higher Maintenance Cyclosporine Dose Decreases the Risk of Graft Failure in North American Children: A Report of the North American Pediatric Renal Transplant Cooperative Study, J Am Soc Nephrol, vol. 7, no. 4, pp. 550-555, 1996.
J. M. Sorof, Sullivan, E. K., Tejani, A., and Portman, R. J., Hypertensive medication and renal allograft failure: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), J Am Soc Nephrol, vol. 10, pp. 1324-30, 1999.
A. Tejani and Sullivan, E. K., The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 4, pp. 1-7, 1999.
E. K. Sullivan, Kerman, R. H., and Tejani, A., Impact of HLA Matching, Type of Crossmatch and Immunosuppresive Therapy on Primary Pediatric Cadaver Renal Allograft Survival, Transplant Proc, vol. 27, no. 1, pp. 656-657, 1995.
V. R. Dharnidharka, Ho, P. L., Stablein, D. M., Harmon, W. E., and Tejani, A., Initial immunosuppression with Mycophenolate or Tacrolimus is not associated with increased risk for post-transplant lymphoproliferative disorder: a North American Pediatric Cooperative Study (NAPRTCS) Report, 2001.
M. A. Baum, Stablein, D. M., Panzaarino, V. M., Tejani, A., Harmon, W. E., and , Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis, Kidney Int., vol. 59, pp. 328-33, 2001.
A. Tejani, Sullivan, E. K., ,, Fine, R. N., Harmon, W. E., and Kohaut, E. C., Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 3, pp. 293-300, 1999.
S. Bartosh, Ho, P. L., and Tejani, A., Racial differences in donor source, matching, rejection and outcome in Pediatric renal transplantation (PRT), 2002.
M. R. Benfield, Tejani, A., Harmon, W. E., McDonald, R., Stablein, D. M., McIntosh, M., and Rose, S., A Randomized Multicenter Trial of OKT3 mAbs Induction Compared With Intravenous Cyclosporine in Pediatric Renal Transplantation, Pediatric Transplantation, vol. 9, pp. 282-292, 2005.
A. Tejani, Harmon, W. E., Benfield, M., Elshihabi, I., McDonald, R., Stablein, D., Rose, S., Strom, T., and Suthanthiran, M., A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation, 2000.